Indian pharma eyes massive 2030 target after hitting record $31 bn in exports

The Indian pharmaceutical industry has grown from about $20 billion in 2014 to nearly $60 billion in 2026, and is expected to touch $130 billion by 2030, with exports alone looking to clock $50 billion, said Mr Mohit Yadav, Joint Secretary, Department of Commerce, while speaking at an outreach programme organised by the  Department of Commerce at the Pharmaceuticals Export Promotion Council of India (Pharmexcil) centre in Mumbai. Highlighting India’s export trajectory, growing market diversification and deepening trade relations with key partner countries, he said, the Government was working closely with industry to strengthen export capabilities, improve competitiveness and support India’s transition from volume-led exports to value-led exports. The industry enters this high-growth phase on the heels of a blockbuster performance in the fiscal year ending March 2026, where outbound pharma shipments scaled a record-breaking $31 billion, according to a report.

Please visit our youtube channel https://www.youtube.com/@ikargosindia for fortnightly logistics news analysis and more!